Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
RUBICON
00
RUBICON

Rubicon Research Ltd.

NSE: RUBICON
BSE: 544578
Sector: Healthcare
Industry: Pharmaceuticals
1,390.40+10.8 (+0.78%)
8 Jul, 12:00 AM

Stock Scores

Quality Score

87.5 / 100

Value Score

5.2 / 100

Price Momentum Score

71.2 / 100

QVM Score

56.2 / 100

Key Metrics

Market Cap
22994.90
P/E (TTM)
93.20
P/B
17.84
P/S (TTM)
13.11
EV/EBITDA
57.33
CAPE (5Y)
284.18
ROE (TTM)
26.97
ROCE (TTM)
27.75
ROA (TTM)
13.06
Avg 3Y ROE
27.70
Earnings 3Y CAGR
-
Sales 3Y CAGR
64.57
Sales 5Y CAGR
-
Debt/Equity
0.24
Consensus TP
1175.00
Strong Buy %
-
Promoter Holding
59.86
Pledged %
0.00

Share Price

Track Rubicon Research Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 1.62 %
Low
1,286.2
High
1,415.0
1 Month returns: 17.69 %
Low
1,163.1
High
1,468.7
1 Year returns: –
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Rubicon Research Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Rubicon Research Ltd. Shareholding Pattern

Quarterly breakdown of Rubicon Research Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Rubicon Research Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Rubicon Research Ltd.?
The current share price of Rubicon Research Ltd. is ₹ 1,390.40 as of 8 Jul 2026.
What is the market capitalisation of Rubicon Research Ltd.?
The market capitalisation of Rubicon Research Ltd. stands at ₹ 22,994.90 Cr.
What is the PE ratio of Rubicon Research Ltd.?
The Price-to-Earnings (PE) ratio of Rubicon Research Ltd. is 93.20 as of the latest trailing twelve months data.
What is the ROE and ROCE of Rubicon Research Ltd.?
Rubicon Research Ltd. has a Return on Equity (ROE) of 26.97% and a Return on Capital Employed (ROCE) of 27.75% as per the latest financial reports.
What is the 52-week high and low of Rubicon Research Ltd.?
The 52-week high of Rubicon Research Ltd. is - and the 52-week low is -.
What is the dividend yield of Rubicon Research Ltd.?
The dividend yield of Rubicon Research Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Rubicon Research Ltd.?
Foreign Institutional Investors (FII) hold 7.54%, Domestic Institutional Investors (DII) hold 7.45% and retail/public investors hold 22.35% of Rubicon Research Ltd. shares.
What sector does Rubicon Research Ltd. belong to?
Rubicon Research Ltd. operates in the Healthcare sector.
What is the beta of Rubicon Research Ltd.?
The beta of Rubicon Research Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Rubicon Research Ltd.?
The 14-day Relative Strength Index (RSI) of Rubicon Research Ltd. is 62.28, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.